FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Shah, A., Bloomquist, E., Tang, S., Fu, W., Bi, Y., Liu, Q., Yu, J., Zhao, P., Palmby, T. R., Goldberg, K. B., Chang, C. J. G., Patel, P., Alebachew, E., Tilley, A., Pierce, W. F., Ibrahim, A., Blumenthal, G. M., Sridhara, R., Beaver, J. A., Pazdur, R.
The American Association for Cancer Research (AACR)
Published 2018